FDA.reportPublic FDA data

polatuzumab vedotin-piiq 140 MG Injection

RxCUI
2174095
RxNorm name
polatuzumab vedotin-piiq 140 MG Injection
Display name
polatuzumab vedotin-piiq 140 MG Injection
Full name
polatuzumab vedotin-piiq 140 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761121Polivypolatuzumab vedotin-piiq351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
POLIVYPOLATUZUMAB VEDOTINGenentech, Inc.20a16ab2-f338-4abb-9dcd-254bd949a2bc2026-03-24Warnings, Adverse reactionsExact identifier
rxcui: 2174095

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
20a16ab2-f338-4abb-9dcd-254bd949a2bcpolatuzumab vedotin-piiq 140 MG InjectionPSN14These highlights do not include all the information needed to use POLIVY safely and effectively. See full prescribing information for POLIVY. POLIVY ® (polatuzumab vedotin-piiq) for injection, for intravenous use Initial U.S. Approval: 201920260324
20a16ab2-f338-4abb-9dcd-254bd949a2bcpolatuzumab vedotin-piiq 140 MG InjectionSCD14These highlights do not include all the information needed to use POLIVY safely and effectively. See full prescribing information for POLIVY. POLIVY ® (polatuzumab vedotin-piiq) for injection, for intravenous use Initial U.S. Approval: 201920260324